Use of 2-6- (3-Amino-piperidin-l-yl) - 3-methyl-2, 4-dioxo-3, 4-dihydr0-2H-pyrimidin-1-ylmet hyl4-fluoro-benzonitrile

Details for Australian Patent Application No. 2007296556 (hide)

Owner Takeda Pharmaceutical Company Limited

Inventors Covington, Paul; Christopher, Ronald J.; Ogawa, Atsushi

Agent Griffith Hack

Pub. Number AU-A-2007296556

PCT Pub. Number WO2008/033851

Priority 60/894,628 13.03.07 US; PCT/ US2006/035958 13.09.06 US

Filing date 11 September 2007

Wipo publication date 20 March 2008

International Classifications

A61K 31/4439 (2006.01)

A61K 31/513 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 5/00 (2006.01) Drugs for disorders of the endocrine system

A61P 5/50 (2006.01) Drugs for disorders of the endocrine system

A61P 31/18 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

7 May 2009 PCT application entered the National Phase

  PCT publication WO2008/033851 Priority application(s): WO2008/033851

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007296558-Media player with imaged based browsing

2007296555-Process and intermediates for preparing integrase inhibitors